Tuberculosis treatment success rate in Cambodia
Cambodia: Tuberculosis treatment success rate was 96.0% in 2023. ▲ Rising
Tuberculosis treatment success rate in Cambodia, 1994–2023
Source: WHO (2025) – with minor processing by Our World in Data. Measured in %.
Analysis
Cambodia recorded 96.0% for tuberculosis treatment success rate in 2023. That is the highest value across all 30 years on record.
That represents a change of up 3.2% over ten years.
Over the whole period, tuberculosis treatment success rate in Cambodia peaked at 96.0% in 2019 and was at its lowest, 84.0%, in 1994.
Cambodia ranks 16th of 206 countries on this measure, in the top 10%.
The long-run direction has been consistently rising across the 30 years of available data.
Tuberculosis treatment success rate in Cambodia, year by year
| Year | % | Change |
|---|---|---|
| 1994 | 84.0% | — |
| 1995 | 91.0% | +8.3% |
| 1996 | 94.0% | +3.3% |
| 1997 | 91.0% | -3.2% |
| 1998 | 95.0% | +4.4% |
| 1999 | 93.0% | -2.1% |
| 2000 | 91.0% | -2.2% |
| 2001 | 92.0% | +1.1% |
| 2002 | 92.0% | +0.0% |
| 2003 | 93.0% | +1.1% |
| 2004 | 91.0% | -2.2% |
| 2005 | 91.0% | +0.0% |
| 2006 | 92.0% | +1.1% |
| 2007 | 93.0% | +1.1% |
| 2008 | 94.0% | +1.1% |
| 2009 | 94.0% | +0.0% |
| 2010 | 89.0% | -5.3% |
| 2011 | 94.0% | +5.6% |
| 2012 | 94.0% | +0.0% |
| 2013 | 93.0% | -1.1% |
| 2014 | 93.0% | +0.0% |
| 2015 | 94.0% | +1.1% |
| 2016 | 94.0% | +0.0% |
| 2017 | 94.0% | +0.0% |
| 2018 | 94.0% | +0.0% |
| 2019 | 96.0% | +2.1% |
| 2020 | 96.0% | +0.0% |
| 2021 | 95.0% | -1.0% |
| 2022 | 96.0% | +1.1% |
| 2023 | 96.0% | +0.0% |
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 1990s | 91.3% | 84.0% | 95.0% | 6 |
| 2000s | 92.3% | 91.0% | 94.0% | 10 |
| 2010s | 93.5% | 89.0% | 96.0% | 10 |
| 2020s | 95.8% | 95.0% | 96.0% | 4 |
Countries ranked near Cambodia
- 14 Kuwait 99.0% compare
- 15 Malta 98.0% compare
- 16 Bangladesh 96.0% compare
- 16 Ethiopia 96.0% compare
- 16 Tanzania, United Republic of 96.0% compare
More health data for Cambodia
- Un projection of annual infant deaths, annual growth rate -1.78 % change on previous year (2100)
- Heat deaths vs projected death rates, annual growth rate 0.572 % change on previous year (2090)
- Estimated changes in temperature-related death rates compared to projected death rates 1,125 deaths per 1,000 people (2090)
- Number of infants who die before age 1 1,047 deaths (2100)
- Population ages 75-79, female, annual growth rate 6.48 % change on previous year (2025)
- Population ages 75-79, female, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 75-79, female, per capita 0.0068 units per person (2025)
- Population ages 75-79, male, annual growth rate 5.75 % change on previous year (2025)
- Population ages 75-79, male, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 75-79, male, per capita 0.0042 units per person (2025)
Frequently asked questions
- What is tuberculosis treatment success rate in Cambodia?
- Tuberculosis treatment success rate in Cambodia was 96.0% in 2023, according to WHO (2025) – with minor processing by Our World in Data.
- What is the highest tuberculosis treatment success rate recorded in Cambodia?
- The highest recorded value was 96.0% in 2019.
- What is the lowest tuberculosis treatment success rate recorded in Cambodia?
- The lowest recorded value was 84.0% in 1994.
- How does Cambodia rank for tuberculosis treatment success rate?
- Cambodia ranks 16th out of 206 countries with data for 2023.
- Is tuberculosis treatment success rate rising or falling in Cambodia?
- Over the last ten years it is up 3.2%. The long-run trend across the full record is rising.
- Where does this Cambodia data come from?
- The figures come from WHO (2025) – with minor processing by Our World in Data, published as part of Tuberculosis treatment success rate. Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 30 observations, free to reuse under CC BY 4.0 (Our World in Data).
About this data
Treatment success rate among new and relapse cases.